'Project Renewal': FDA updates older Genentech cancer drug label
The FDA today said it approved updated labeling for Roche’s cancer drug Xeloda (capecitabine) tablets as part of a pilot project …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
